155 related articles for article (PubMed ID: 34506251)
1. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
Zhao Y; Hu S; Zhang J; Cai Z; Wang S; Liu M; Dai J; Gao Y
Bioengineered; 2021 Dec; 12(1):5641-5654. PubMed ID: 34506251
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of the prognostic significance and oncogenic role of GXYLT2.
Song YB; Bao WG; Liu DH; Wei LQ; Yang ST; Miao XJ; Lin CY; Li HJ; Lan D; He HM
Medicine (Baltimore); 2023 Nov; 102(46):e35664. PubMed ID: 37986328
[TBL] [Abstract][Full Text] [Related]
3. Analyzing the expression and clinical significance of CENPE in gastric cancer.
Wang J; Li X; Qiang X; Yin X; Guo L
BMC Med Genomics; 2024 May; 17(1):119. PubMed ID: 38702677
[TBL] [Abstract][Full Text] [Related]
4. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
Liu SS; Wan QS; Lv C; Wang JK; Jiang S; Cai D; Liu MS; Wang T; Zhang KH
BMC Cancer; 2024 Apr; 24(1):465. PubMed ID: 38622522
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of JAM 3 in gastric cancer: An observational study from TCGA and GEO.
Zhao Q; Lian J; Pang K; Wang P; Ge R; Chu Y
Medicine (Baltimore); 2023 Apr; 102(17):e33603. PubMed ID: 37115068
[TBL] [Abstract][Full Text] [Related]
6. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Fang F; Zhang T; Lei H; Shen X
PeerJ; 2023; 11():e15613. PubMed ID: 37404478
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming involves in transition of activated/resting CD4
Sun Y; Liu L; Fu Y; Liu Y; Gao X; Xia X; Zhu D; Wang X; Zhou X
Front Immunol; 2023; 14():1275461. PubMed ID: 38090588
[TBL] [Abstract][Full Text] [Related]
8. The role of senescence genes in the treatment, prognosis, and tumor microenvironment of gastric cancer.
Xuan J; Li F; Li J; Gong C; Li J; Mo Z; Jin Q
Am J Transl Res; 2023; 15(12):6926-6938. PubMed ID: 38187003
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive evaluation of serum circHAS2 as a novel diagnostic and prognostic biomarker for gastric cancer.
Ma S; Yao Y; Xu Y; Zou M; Zhou M; Abudushalamu G; Chen Y; Cai S; Zhang C; Wu G
Mol Carcinog; 2024 Jan; 63(1):94-105. PubMed ID: 37750590
[TBL] [Abstract][Full Text] [Related]
10. Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer.
Xu H; Huang K; Lin Y; Gong H; Ma X; Zhang D
BMC Med Genomics; 2023 Jun; 16(1):123. PubMed ID: 37277853
[TBL] [Abstract][Full Text] [Related]
11. COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer.
Sun X; Zhang Q; Shu P; Lin X; Gao X; Shen K
Technol Cancer Res Treat; 2023; 22():15330338231218163. PubMed ID: 38112409
[TBL] [Abstract][Full Text] [Related]
12. Identification of Novel Prognostic Biomarkers That are Associated with Immune Microenvironment Based on GABA-Related Molecular Subtypes in Gastric Cancer.
Wang B; Huang L; Ye S; Zheng Z; Liao S
Pharmgenomics Pers Med; 2023; 16():665-679. PubMed ID: 37405024
[TBL] [Abstract][Full Text] [Related]
13. DNM1: A Prognostic Biomarker Associated with Immune Infiltration in Colon Cancer-A Study Based on TCGA Database.
Hu M; Gu J; Su W; Zhang Z; Zhu B; Wang Q; Xing C
Biomed Res Int; 2021; 2021():4896106. PubMed ID: 34888380
[TBL] [Abstract][Full Text] [Related]
14. Integrated Single-Cell and Transcriptome Sequencing Analyses Develop a Ubiquitination-Associated Signature in Gastric Cancer and Identified OTULIN as a Novel Biomarker.
Huang Z; Zhang Z; Tu Y; He H; Qiu F; Qian H; Pan C
Front Biosci (Landmark Ed); 2023 Nov; 28(11):304. PubMed ID: 38062820
[TBL] [Abstract][Full Text] [Related]
15. The high expression of glial cell line-derived neurotrophic factor receptor alpha Ⅱ (
Yang S; Li J; Cai X
Heliyon; 2023 Jul; 9(7):e18291. PubMed ID: 37519699
[TBL] [Abstract][Full Text] [Related]
16. Screening of coexpression genes of immune cells in breast cancer tissues.
Zhang YY; Gan YM
Medicine (Baltimore); 2024 Jan; 103(1):e36211. PubMed ID: 38181289
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and immune characteristics of APOE in gastric cancer.
Peng X; Cai Z; Chen D; Ye F; Hong L
Aging (Albany NY); 2023 Dec; 15(23):13840-13853. PubMed ID: 38054821
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients.
Sha R; Zhang J; Meng F; Zhaori G
Medicine (Baltimore); 2023 Oct; 102(40):e35030. PubMed ID: 37800836
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Cyclin-Dependent Kinase 1 as an Independent Prognostic Factor for Gastric Cancer Based on Statistical Methods.
Zhang X; Ma H; Zou Q; Wu J
Front Cell Dev Biol; 2020; 8():620164. PubMed ID: 33365314
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis and experimental validation of tumorigenic role of PPIA in gastric cancer.
Liu J; Wang Y; Zhao Z; Ge Y
Sci Rep; 2023 Nov; 13(1):19116. PubMed ID: 37926757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
